Announcing the Return of The Canadian Institute’s 11th Annual Forum on Pharma Patents to Toronto
Get ready for the return of The Canadian Institute's Pharma Patents program this October.
Do not miss presentations from the likes of Ildiko Mehes, Vice President General Counsel at Teva Canada on the application of s. 8 cases from Ramipril to Alendronate, and Nathaniel Lipkus, Partner at Gilbert’s LLP and Cyndee Todgham Cherniak, Counsel at LexSage Professional Corporation, on CETA’s impact on the pharmaceutical industry.
Other topics that will be covered include:
• Leveraging patents, regulatory pathways, data exclusivity, agreements, pricing and patent expiries to harness the maximum value for brand or generic products
• Developing strategic approaches to patent drafting, prosecution and the application of the ‘promise of the patent’ cases
• Exploiting the emerging opportunities from biologics to SEBs
And much more!
Conference Title: The Canadian Institute’s 11th Annual Forum on Pharma Patents
Date: October 29-30, 2012
Location: Marriott Bloor Yorkville – Toronto, ON
About The Canadian Institute
For over 25 years, The Canadian Institute's conferences, summits and executive briefings have provided the business intelligence that Canadian decision makers need to respond to challenges and opportunities both here at home, and around the world. The Canadian Institute operates as a think tank, monitoring trends and developments in all major industry sectors, in the law, and in public policy, with a view to providing information on the leading edge. Headquartered in Toronto, The Canadian Institute produces over 180 events a year, attended by thousands of senior and C-level delegates from across the country. For more information, visit http://www.CanadianInstitute.com.
Media passes are issued at the discretion of The Canadian Institute and must be arranged in advance. Passes require two business days to process. Media can register in advance. For media accreditation contact:
Tel: 416-927-0718 Ext. 7308 or email@example.com